CCassured’s Post

🌍 INNOVATION: THE ONCOSCREEN PROJECT🌍   We are excited about the advancement of the ONCOSCREEN project, which aims to transform the way colorectal cancer is screened and diagnosed in Europe. 🚀   How does it work? 🔬Comprehensive validation: The tools developed will be tested extensively in clinical trials, with the participation of 4,100 citizens and patients from 10 European countries.   🧑🏻🤝🧑🏽 Participatory approach: ONCOSCREEN will incorporate the opinions and perspectives of citizens and patients through a participatory co-design method, coupled with open innovations and FAIR (Findable, Accessible, Interoperable, and Reusable) data.   🎯 End goal: The end goal is for these innovative solutions to be adopted by public health systems and in daily clinical practice across Europe. ONCOSCREEN’S mission is to make bowel cancer screening more accessible and effective for everyone.   Join us on this journey to improve the detection and treatment of digestive cancers in Europe! 🌟   #ONCOSCREEN #Innovation #Europe #CRC #EarlyDiagnose #ColorectalCancer #EUCancer

🌍 INNOVATION: THE ONCOSCREEN PROJECT🌍 We are excited about the advancement of the ONCOSCREEN project, which aims to transform the way colorectal cancer is screened and diagnosed in Europe. 🚀 How does it work? 🔬Comprehensive validation: The tools developed will be tested extensively in clinical trials, with the participation of 4,100 citizens and patients from 10 European countries. 🧑🏻🤝🧑🏽 Participatory approach: ONCOSCREEN will incorporate the opinions and perspectives of citizens and patients through a participatory co-design method, coupled with open innovations and FAIR (Findable, Accessible, Interoperable, and Reusable) data. 🎯 End goal: The end goal is for these innovative solutions to be adopted by public health systems and in daily clinical practice across Europe. ONCOSCREEN’S mission is to make bowel cancer screening more accessible and effective for everyone. Join us on this journey to improve the detection and treatment of digestive cancers in Europe! 🌟 https://oncoscreen.health/   #ONCOSCREEN #Innovation #Europe #CRC #EarlyDiagnose #ColorectalCancer #EUCancer

In addition to raising awareness about pancreatic cancer and palliative care, the RELEVIUM project is dedicated to improving patients' quality of life through an innovative AI-driven solution. 💜 #PancreaticCancerAwarenessMonth The main phase of the project features the RELEVIUM Randomized Controlled Trial (RELEVIUM-RCT), which will take place across five leading cancer centers in Belgium, Estonia, France, Israel, and Germany. This trial aims to: ✅ Assess the effectiveness of multimodal interventions in enhancing the quality of life for advanced PDAC patients. ✅ Evaluate cost-effectiveness, health equity, and access to palliative care. ✅ Explore the reduction of family stress and the potential of innovative technologies to deliver timely, supportive care. This study is a significant step forward in addressing the complex needs of PDAC patients and their loved ones. Stay tuned for updates as we move ahead! 🌐 Learn more at www.releviumproject.eu

🫁 #LungCancerAwarenessMonth 🎗️ 📈 Every year, it is estimated that about 2.4M people are diagnosed with #lungcancer across the world. Despite progress in the field of research, medicines, #diagnostics and #healthcare, lung cancer remains a leading cause of death, with 1.8M deaths in 2020. Raising awareness and supporting those impacted by this disease is therefore so important this month. 🩻 🧬 Non-small cell lung cancer, #NSCLC, accounts for about 85% of all lung cancers, but not all NSCLC cases are the same. #Genomicprofiling using cutting edge technologies can further define the complexity of this disease, and is critical for the uptake of #precisiononcology. Detection of #clincallyactionable #biomarkers is a game changer in the growing area of #personalisedmedicines. 💊 💡#Liquidbiopies in #cancerresearch are minimally invasive and represent a promising step forward. Allowing for detection and monitoring of circulating tumour DNA (#ctDNA) through advancements in diagnostics, it has the potential for improved clinical outcomes, especially if there is a delay due to limited or unavailable tissue biopsies. 🩸 🙏🏼 As we recognize #LCAM through November, emphasizing the need for #equitableaccess to these advancements is critical, so that we strive for a future where no one is left behind in the fight against lung cancer 🌏 #moleculartesting #targetedtherapies #lungcancerawareness

🔍 Curious about the latest developments in lung cancer and screenings available in Central and Eastern Europe (#CEE)? Join us tomorrow for "Accelerating action: lessons from lung cancer screening in CEE" conference, organized jointly by the Institute for Social Policy Development and The Health Policy Partnership within the framework of the Lung Cancer Policy Network. 🗓️ Date: May 14, 2024 🕒 Time: 14:00 CEST This will be a dynamic and result-oriented discussion involving well-known Polish and foreign clinicians, researchers, policymakers, and other stakeholders. Tomorrow, experts will share their knowledge and experience regarding the lung cancer situation in Central and Eastern Europe, including the important role of LDCT screening in saving the lives of lung cancer patients. Optimal screening is a game-changer in the battle against cancer, with calculations indicating it can save even 38,000 lives! This figure represents more than half of the total number of individuals diagnosed with lung cancer in the region. 🔗 Secure your spot now and join us online to follow the discussion! Register here: https://lnkd.in/d7ZHGXky #LCPN #IRSS #LungCancerAwareness #Screening #CEE #CancerCare

As we observe the Lung Cancer Awareness Month, it's vital to recognise the essential role our lungs play in sustaining life, as they enable us to breathe and provide oxygen to our bodies. With the average person able to hold their breath for only 30 to 90 seconds, the importance of healthy lungs becomes clear. Poor lung health can severely impact daily life, making early detection of lung cancer through regular screening crucial, especially since this common cancer often goes undetected until advanced stages. By raising awareness and encouraging screenings, particularly for those at higher risk, we can take proactive steps to protect our lungs and ensure a healthier living. Remember, healthy lungs are the foundation of a healthy life. #lungcancerawareness #RewritingCancer

Cancer care is evolving rapidly. Together, we can transform cancer care and develop medical innovations that improve and extend the lives of those facing this disease. At Novartis, we are proud to partner with All.Can Belgium. By collaborating with patient and care representatives, healthcare professionals, health experts, policymakers and other industry representatives, we aim to enhance the efficiency of cancer care in Belgium. If you are interested in the latest developments in oncology, we invite you to attend the free conference “Cancer Care: The Future is Now” organised by All.Can Belgium in Brussels on Wednesday, 6 November. At this event, you will have the opportunity to explore: 💡 The impact of innovation in oncology on healthcare organisations 🔬 Clinical research in the era of molecular oncology 🗝️ Access to innovation 📊 The role of AI, data and telehealth in cancer care Admission is free, but registration before 4 November is mandatory. Information and registrations via https://lnkd.in/esGVg-qH 🎟️ #CancerCare #TheFutureIsNow #NovartisTogether

Next Generation Sequencing (NGS) holds tremendous promise to advance cancer care in APAC, but a combination of policy, clinical and reimbursement barriers stand in the way of equitable access. Join us for the regional launch of the Asia Pacific Medical Technology Association (APACMed) White Paper, “Advancing Patient Access to NGS for Cancer in APAC”, where Vista Health and APACMed will convene local and global NGS experts to discuss key messages from the White Paper, highlight global best practices from Europe, and share insights on enabling NGS access across APAC. Key messages from the White Paper include: 1) The transformative potential of NGS in cancer care   2) Policy considerations to improve NGS access across the APAC region  3) A validated fit-for-purpose Value Assessment Framework (VAF) to comprehensively evaluate NGS Secure your seat and register now at: https://lnkd.in/gWM3R_S6 Yoonla Choi, Krystal Barter, Sandi Deans, Richard Rosenquist Brandell, Tiffany Boughtwood, Aaron Shen, Mikaela Tham, Samuel Goh, Yang Shen Teh, Will Brown #nextgeneration #ngs #oncology #cancer #vaf #framework #policy #APAC #asiapacific #whitepaper #patientaccess #healthcare #cancercare #publichealth #vistahealth

The 6th Annual European Cancer Forum is just ONE WEEK away! 🎉 Our CEO Antonella Cardone will join an incredible lineup of speakers to discuss “Navigating a Changing Cancer Care System” during Session III on 4 December 2024. This year’s theme, “Implementing a Sustainable Future for Cancer Care,” will focus on: 🏥 Optimizing patient pathways for early and effective care. 🔬 Expanding access to innovative screening and diagnostic technologies. 🤝 Showcasing learnings from best practices in early detection and multidisciplinary team care.   Registrations are still open: https://lnkd.in/eYP9ajnA   💭What measures do you think should be implemented to help cancer patients navigate the rapidly evolving cancer care system more effectively? Share your thoughts in the comments below! ⬇️ #EuropeanCancerForum #CancerCareInnovation #CollaborationForHealth #BeatingCancerPlan #FutureOfHealthcare #ECBP #EUCancerPlan #CancerPatientsEurope #CancerScreening #EarlyDetection #HealthEquity #HealthInequalities #EUHEalth #CancerAwareness #Oncology Jacki Davis Tuula Helander Martin Bailey Matias Olsen AI for Social Good EUCOPE - European Confederation of Pharmaceutical Entrepreneurs IHE - The Swedish Institute for Health Economics Digestive Cancers Europe MSD Europe European Oncology Nursing Society (EONS) European Parliamentary Forum Europa Uomo EU Make Sense Campaign Sosiaali- ja terveysministeriö European Commission European Parliament Council of the European Union

Advancements in care and personalized treatments have transformed patient outcomes for lung cancer, enabling more people to potentially live longer, healthier lives.[1] However, in emerging markets, lung cancer deaths remain to be high often due to late diagnosis and limited access to quality care.[2]  This #LungCancerAwareness month, Elden’s story motivates us to persist in our efforts to make early screening, diagnosis, and quality of lung cancer care available to everyone. We aim to collaborate with governments and the private sector to implement resource-stratified solutions in emerging markets. These actions are crucial for saving lives with hope to eliminate lung cancer as leading cause of cancer death. #LungCancerAwareness #AstraZeneca #RewritingCancer  [1] https://lnkd.in/dwFz6NFS accessed October 2024   [2] Nwagbara UI, et al. Globalization and Health 2020;16(1):23. 8 Ti Hwei How Susan Mccutcheon Pei-Chieh Fong Sabine Luciani Marq Marquez Peter Raouf Eldana Sauran Svetlana Yanchuk Francisco Gonzalez Hernandez, MD, MSc Ashwini Saha Doreen Tay Carmen Vargas